| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |